Severity
Moderate
FDA Food recall · Reported December 25, 2013
Firm is recalling dietary supplements containing a raw material which may contain >0.3 ppb chloramphenicol
National Enzyme Co recalled Dietary Supplements packaged in the following configurations: (1)Transformation Profess… - a moderate-severity action.
Dietary Supplements packaged in the following configurations: (1)Transformation Profess… was recalled by National Enzyme Co in December 25, 2013. Reason: Firm is recalling dietary supplements containing a raw material which may contain >0.3 ppb chloramphenicol. Check the official notice for the remedy. Verify recall #F-0739-2014 with the FDA Food before acting.
The recall
National Enzyme Co issued this moderate-severity FDA Food recall-Firm is recalling dietary supplements containing a raw material which may contain >0.3 ppb chloramphenicol.
Sourced from official FDA Food enforcement records. Verify recall #F-0739-2014 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Food action (record #F-0739-2014) was formally reported on December 25, 2013, with the manufacturer initiating the action on October 30, 2013. It is classified under Moderate severity (Class II), with a current status of Terminated. National Enzyme Co is listed as the recalling firm, operating out of Forsyth, MO. Federal records list the affected scope as 44288 bottles, 6781 bulk capsules;.
The documented reason for this recall is: Firm is recalling dietary supplements containing a raw material which may contain >0.3 ppb chloramphenicol Distribution data in the federal record shows the product reached: Domestic distribution of the product is nationwide with direct accounts in 27 states in all geographical regions. Foreign distribution consists of direct accounts in the following countries: Canada, China, Malaysia, Nor…. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 1 from FDA Food - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
44288 bottles, 6781 bulk capsules;
Related Recalls
6
1 from same agency
Dietary Supplements packaged in the following configurations: (1)Transformation Professional Protocol Digest Enzyme Supplement, Packaged in 45-(SKU 54646), 60-(SKU 52413), 90-(SKU 52520), 120-(SKU 53098) capsule bottles. The firm name on the label is Transformation Enzyme Corp. Houston, TX; (2) 3989V TEC-TPP DIGEST UNL 60' unlabeled 60-(SKU 53571) capsule bottles; (3) Transformation Digest. Packaged in 60-(SKU 54599) capsule bottles. Russian label; (4) Anti-aging Nutrition Health Graph Professional Strength Digest Enzyme Supplement. Packaged in 120-(SKU 54752) bottles. The firm name on the label is Health Graph, Glenview, IL; (5) The Lohad Center for Anti-Aging Digest Enzyme Supplement. Packaged in 90-(SKU 54914) capsules bottles. The firm name on the label is The Lohad Center, Jacksonville, FL. (6) Bulk 3989V TPP-TEC Digest Conv Pa capsules (SKU 92494) packaged in varying quantities within poly bags within corrugated boxes (for domestic distribution) or fiber drums (for international distribution)
Firm is recalling dietary supplements containing a raw material which may contain >0.3 ppb chloramphenicol
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | F-0739-2014 |
| Date reported | December 25, 2013 |
| Date initiated | October 30, 2013 |
| Recalling firm | National Enzyme Co |
| Firm location | Forsyth, MO |
| Affected scope | 44288 bottles, 6781 bulk capsules; |
| Distribution | Domestic distribution of the product is nationwide with direct accounts in 27 states in all geographical regions. Foreign distribution consists of direct accounts in the following countries: Canada, China, Malaysia, Norway, Slovakia, South… |
Profile values are sourced directly from the official FDA Food enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Food record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Food, reported December 25, 2013. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.